Financhill
Back

Recursion Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

RXRX
Recursion Pharmaceuticals, Inc.

Last Price:
$3.68
Seasonality Move:
-27.61%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight buying pressure.

Recursion Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 3.6 Buy
20-day SMA: 3.74 Sell
50-day SMA: 4.2 Sell
200-day SMA: 4.87 Sell
8-day EMA: 3.15 Buy
20-day EMA: 1.99 Buy
50-day EMA: 0.99 Buy
200-day EMA: 0.28 Buy

Recursion Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.01 Buy
Relative Strength Index (14 RSI): 43.96 Sell
Chaikin Money Flow: 4870794 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.51 - 4.29) Sell
Bollinger Bands (100): (3.88 - 5.42) Sell

Recursion Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Recursion Pharmaceuticals, Inc. Stock

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

RXRX Technical Analysis vs Fundamental Analysis

Sell
24
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Is Recursion Pharmaceuticals, Inc. a Buy or a Sell?

Recursion Pharmaceuticals, Inc. Stock Info

Market Cap:
1.9B
Price in USD:
3.67
Share Volume:
14.6M

Recursion Pharmaceuticals, Inc. 52-Week Range

52-Week High:
7.89
52-Week Low:
2.98
Sell
24
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Recursion Pharmaceuticals, Inc. Share Price Forecast

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Recursion Pharmaceuticals, Inc.

Is Recursion Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.01 per share, an increase this year of $0.61 per share, and an increase next year of $0.11 per share.

Technical Analysis of Recursion Pharmaceuticals, Inc.

Should I short Recursion Pharmaceuticals, Inc. stock?

* Recursion Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.